GraniteShares Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
GraniteShares Advisors's EW Position: Q2 2026 in Review
GraniteShares Advisors reduced its Edwards Lifesciences (EW) stake by 17% in Q2 2026, selling an estimated $123K and leaving 7,074 shares worth $640K. The position accounts for 0.41% of the portfolio, ranked #67.
GraniteShares Advisors first reported a position in EW in Q4 2021 and has held it in 15 quarters since. The position peaked at $1.02M in Q2 2024. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- GraniteShares Advisors held 7,074 shares of Edwards Lifesciences worth $640K as of Q2 2026.
- GraniteShares Advisors sold 1,473 Edwards Lifesciences shares in Q2 2026, an estimated $123K.
- Edwards Lifesciences made up 0.41% of GraniteShares Advisors's portfolio in Q2 2026, its #67 holding.
- GraniteShares Advisors first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 15 quarters since.
- GraniteShares Advisors's Edwards Lifesciences position peaked at $1.02M in Q2 2024.
- 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on GraniteShares Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.